The hydrolysis of sulfate ester conjugates is frequently required prior to analysis for a range of analytical techniques including gas chromatography-mass spectrometry (GC-MS). Sulfate hydrolysis may be achieved with commercial crude arylsulfatase enzyme preparations such as that derived from Helix pomatia but these contain additional enzyme activities such as glucuronidase, oxidase and reductase that make them unsuitable for many analytical applications. Strong acid can also be used to hydrolyse sulfate esters but this can lead to analyte degradation or increased matrix interference. In this work, the heterologously expressed and purified arylsulfatase from Pseudomonas aeruginosa is shown to promote the mild enzymecatalysed hydrolysis of a range of steroid sulfates. The substrate scope of this P. aeruginosa arylsulfatase hydrolysis is compared with commercial crude enzyme preparations such as that derived from H. pomatia.
Introduction
Steroid metabolites from both exogenous and endogenous sources are typically excreted in biological fluids as phase II glucuronide or sulfate conjugates.
[1] [2] They are of growing importance in fields such as sports drug testing, [3] the detection of residues in agricultural produce, [4] and medicine. [5] In the context of sports drug testing, hydrolysis of these conjugates may be required prior to routine screening, confirmatory analysis, or more advanced techniques such as gas chromatography-isotope ratio mass spectrometry (GC-IRMS). The hydrolysis of phase II glucuronide conjugates can generally be achieved under mild conditions using the Escherichia coli -glucuronidase enzyme (3.2.1.31).
[3] [6] This approach has remained a mainstay of anti-doping laboratories where enzyme hydrolysis is followed by derivatisation and gas chromatographymass spectrometry (GC-MS) analysis to screen the combined free and glucuronide conjugated steroidal fractions. [7] In contrast, no generally accepted method has been established for the hydrolysis of phase II steroidal sulfate conjugates, and they are not routinely included in human anti-doping screens. [3] [8] [9] Steroid sulfates represent a significant fraction of the steroid metabolites and including them in analysis could improve the sensitivity and retrospectivity of sports drug testing. For example, the analysis of sulfate metabolites can afford greater retrospectivity for the detection of steroidal agents, [10] [11] [12] and may also serve as markers to distinguish between steroids of exogenous and endogenous origin. [12] [13] [14] Other non-steroidal performance-enhancing drugs also afford important sulfate conjugates, including toremifene, [15] andarine, [16] and mesocarb.
[17] [18] Steroid sulfates can be chemically hydrolysed under strong acid conditions, but this can degrade acidsensitive analytes and may also give rise to increased matrix-derived interference in the subsequent GC-MS analysis leading to reduced sensitivity. [3] [19] A range of commercial sulfatase enzymes (EC 3.1.6.1) may be employed, but these crude enzyme preparations typically have additional activities such as -glucuronidase, oxidase or reductase that make them unsuitable for many applications. [3] [19] To address these issues a number of more elaborate protocols have been employed including, glucuronide hydrolysis and extraction of free steroids prior to sulfate hydrolysis, or separation of the sulfate fraction through solid phase extraction prior to strong acid or enzyme hydrolysis. The approaches and challenges associated with analysis of the sulfate fraction have been reviewed in detail. [3] In this work we report a study of the steroid sulfatase activity of the heterologously expressed and purified
Pseudomonas aeruginosa arylsulfatase (PaS) including substrate scope and enzyme kinetic evaluation.
These results are compared against four commercial sulfatase enzyme preparations. The PaS enzyme is shown to hydrolyse a range of steroid sulfates, with a substrate scope similar to that observed for Helix pomatia arylsulfatase preparation (HpS), the leading commercial crude enzyme preparation for the hydrolysis of steroid sulfates. Hydrolysis in a urine matrix is demonstrated for dehydroepiandrosterone 3-sulfate and epiandrosterone 3-sulfate. In contrast to HpS, which displays significant -glucuronidase activity, PaS is a purified enzyme that allows for the selective hydrolysis of sulfate esters in the presence of glucuronide conjugates. This is illustrated by a short chemoenzymatic synthesis of 5α-androstane-3β,17β-diol 17-glucuronide (ADG) 1.
Experimental

Materials
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Unless otherwise stated, chemicals were purchased from Sigma-Aldrich (Castle Hill, Australia was synthesised from T using literature methods. [20] Milli-Q water was used in all aqueous solutions and in the liquid chromatography mobile phase. Liquid chromatography (gradient) grade methanol obtained from Merck (Kilsyth, Australia) was used for preparing the LC mobile phase and steroid standard solutions.
Synthesis of steroid sulfates
To explore the substrate range of the sulfatases investigated, steroid sulfates were synthesised by literature methods. [ 
Commercial enzymes
Four arylsulfatase preparations (EC 3.1.6.1) were purchased from Sigma-Aldrich for comparison with PaS.
Three were derived from molluscs: H. pomatia sulfatase (HpS) (product number S9626), Haliotis rufescens (abalone) sulfatase (HrS) (S9754), and Patella vulgata sulfatase (PvS) (S8629). Stock solutions of each were prepared by dissolving 10 mg of solids per ml of 250 mM ammonium acetate at pH 6.9. The fourth preparation was Aerobacter aerogenes sulfatase, purchased as a solution in aqueous glycerol (S1629). The bacterium from which this fourth sulfatase is derived is also known as Klebsiella pneumoniae [24] and since this name is used exclusively in current literature it is referred to here as K. pneumoniae sulfatase (KpS).
The four commercial sulfatase preparations are reported to have -glucuronidase activity in the SigmaAldrich product information. One other sulfatase, from Flavobacterium heparinum (Pedobacter heparinus), is commercially available. This is classified as a disulfoglucosamine-6-sulfatase (EC 3.1.6.11) and was not evaluated as part of this research. [25] PaS preparation
The protein sequence for PaS was obtained from Genbank (Accession No. AAG03573.1); derived from the P.
aeruginosa genome sequence. [26] The sequence was submitted to DNA2. conjugates were separated using an Agilent (Mulgrave, Australia) 1260 UHPLC system with a Grace (Rowville, Australia) C18 column (50 mm with 5 mm guard column, 2 mm diameter, 1.8 m particle size).
The mobile phase consisted of 58% methanol and 42% aqueous ammonium acetate for analysis of steroid sulfates or 62% methanol and 38% aqueous ammonium acetate for steroid glucuronides. Both mobile phases had a final concentration of 10 mM ammonium acetate. Analytes were ionised by atmospheric pressure electrospray ionisation (AP-ESI) with an Agilent 6120 quadrupole mass spectrometer: estrone (E), the steroid sulfates and the steroid glucuronide were monitored in negative mode for the proton-loss (supplementary table 1 ).
Enzyme assays. The mollusc enzyme preparations HpS, HrS, or PvS were assayed in 50 mM ammonium acetate at pH 5.0 (pH was selected according to the activity defined by Sigma-Aldrich and the buffer was selected for compatibility with LC-MS), KpS was assayed in 50 mM Tris-HCl at pH 7.4, [27] and PaS in 50 mM
Tris-acetate at pH 8.8. [28] Each enzyme preparation was assayed for protein concentration using the Bradford assay with bovine serum albumin as a standard. The final enzyme concentrations used in the various assays are listed in the Supporting Information (supplementary table 2 ). Reaction components to be analysed by LC-MS were centrifuged at 16000 × g for 3 min before transferring to clean vials for preincubation in a temperature controlled autosampler. All reactions were performed at 37 °C. Aliquots of enzyme and substrate were prepared and pre-incubated at 37 °C for 3 min before mixing enzyme with substrate to start reactions. Samples of the reaction were quenched by either addition of aqueous potassium hydroxide solution (1 M) for PNP detection or injection into LC mobile phase for analysis of steroid sulfate hydrolysis.
Substrate scope studies (Table 1 ) used 100 µM steroid sulfate. For kinetic analysis (Table 2 ; Supporting Information, supplementary figure 2), the substrate concentration range was prepared by serial two-fold dilution to cover 2.5 to 320 M in reactions. Each enzyme-substrate combination was tested in three independent technical replicates (i.e. prepared and analysed at different times, but with the same samples of enzyme and substrate). Non-linear regression was used to fit concentration rate data to the MichaelisMenten model or to a model with substrate inhibition included [29] to estimate kinetic parameters.
Evaluation of PaS activity in a urine matrix
The collection of urine samples was conducted with approval of the Australian National University Human
Research Ethics Committee. ) and overnight incubation at 37 °C. Free steroids were isolated by solid phase extraction using an Agilent ABS Elut NEXUS® extraction cartridge (60 mg, 3 cc,) that was conditioned with methanol (3 mL) and water (3 mL), then loaded with the hydrolysis reaction and washed with aqueous sodium hydroxide solution (1 mL, 0.1 M) and water (3 mL), before elution with methanol (3 mL). The eluant was evaporated to dryness under nitrogen at 60 °C before the liberated steroids were derivatised to form trimethylsilyl (TMS) ethers and TMS enol ethers using N-methyl-N-(trimethylsilyl)trifluoroacetamide/ammonium iodide/dithiothreitol (50 L, 1000:2:4 w/v/v) at 80 °C for 60 min. The final extracts were dried under nitrogen at 60 °C before being reconstituted in n-dodecane (50
Hydrolysis of steroid sulfates by
L) for GC-MS-MS analysis.
Detection of free steroids by GC-MS-MS of TMS derivatives. An Agilent 7000B GC-MS-MS was employed.
The GC column was an Agilent J&W HP5-MS (30 m  0.25 mm  0.25 m) with helium as carrier gas.
Sample injections (1 L) were made in pulsed-splitless mode with an injector temperature of 250 °C. The column temperature was initially held at 182 °C for 1 min, then was increased at 2 °C min -1 to 220 °C and held for 5 min, then increased to 310 °C at 30 °C min -1 and held for 1 min. Head pressure was programmed to maintain a constant flow rate of 1.2 mL min -1
. The MS transfer line was set at 300 °C and the ion source was operated in positive electron ionisation (+EI) mode with an ionization energy of 70 eV. Nitrogen was used for the collision gas at 1.5 mL min -1 . Instrument control and processing was performed using Agilent MassHunter® software. Multiple reaction monitoring (MRM) was used to identify derivatised DHEA and EA as specified in the Supporting Information (supplementary table 3), with limit of detection for both analytes at 0.1 ng mL -1
. Specificity for both steroids was evaluated following injection of neat standards to ensure there was no 'crosstalk' between the MRM transitions.
Synthesis of 5-androstane-3,17-diol 17-glucuronide (ADG)
1 [30] 5-androstane-3,17-diol 3-sulfate (ADS) triethylammonium salt 2. Epiandrosterone 3-sulfate triethylammonium salt [21] [22] 3 (198 mg, 0.42 mmol) in distilled methanol (2 mL) was added drop-wise to solid sodium borohydride (86 mg, 2.27 mmol, 5.4 equiv.) at 0 °C. After the vigorous reaction had subsided, 9 the reaction was allowed to warm to room temperature and stirred until complete by TLC. ) [31] and -D-glucuronyl fluoride 5 (2.3 mg, 10.8 mol, 5 equiv.) [31] dissolved in sodium phosphate buffer (220 L, 50 mM, pH 7.5) were added and the reaction incubated without agitation at 37 °C for 2 d. The reaction was then subjected to solid-phase extraction to remove non-volatile salts and other reaction components. [32] A Waters (Rydalmere, Australia) Oasis WAX SPE cartridge (60 mg, 3 cc) was conditioned with methanol (1 mL) and milliQ water (3 mL). The crude reaction mixture was loaded onto the cartridge and washed with aqueous formic acid (3 mL, 2% v/v), milliQ water (3 mL), and finally with ammonium hydroxide in methanol (9 mL, 5% v/v). The appropriate fractions were combined and the 
Results
Sulfatase substrate range
Our initial research objective was to evaluate the four commercially derived sulfatase preparations alongside the heterologously expressed and purified PaS to establish substrate ranges for PNPS and steroid sulfate hydrolysis (Scheme 1). Activity, relative to total protein concentration, was measured by LC-MS or spectrophotometry at a single 100 M substrate concentration. Ten substrates, selected to encompass the structural diversity of commonly occurring steroid sulfates, were tested with each of the five enzymes and the resulting activity scored on a logarithmic scale ( showed the least discrimination between phenolic and secondary hydroxyl-derived steroid sulfates, with similar rates observed for ES and EAS. Interestingly, DHEAS was hydrolysed ten-fold slower than EAS; these two similar substrates showed more consistent rates of hydrolysis with the other enzyme preparations.
Finally, KpS exhibited the lowest sulfatase activity, with 240000-fold less activity per gram of protein than PaS for the model substrate PNPS. Furthermore, KpS showed no detectable hydrolysis activity for any of the steroid sulfates tested.
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The two most active and promiscuous sulfatases PaS and HpS were selected for further analysis. The commercial sulfatase preparation HpS gave the broadest substrate range, hydrolysing eight of the ten substrates. The heterologously expressed and purified PaS was free of glucuronidase activity and had strong arylsulfatase activity on seven of the substrates tested (Table 1) .
Kinetic analysis of P. aeruginosa and H. pomatia sulfatases
Substrate-saturation kinetics was measured in triplicate for PaS and HpS with four representative substrates: PNPS, ES, EAS and TS. Replicates gave consistent results. However, the replicates had greater variation with the poorest substrate, TS, and when substrate inhibition was observed (Supporting Information, supplementary figure 2). Michaelis-Menten substrate saturation kinetics explained the results for all except the hydrolysis of ES by PaS. This combination displayed substrate inhibition and an additional parameter (K I ) was included in the model giving an improved fit to the data. [29] The Michaelis constant (
was in the range of 7 to 90 M for all substrate-enzyme combinations ( 
Hydrolysis of steroid sulfates in urine
DHEAS. Due to the endogenous contribution of urinary DHEA and DHEAS, buffer spikes were required to assess the hydrolysis efficiency of PaS (61 ± 4%, n = 3) from spiked DHEAS (100 ng mL -1 DHEA equiv.).
Method recovery without urine matrix contribution was assessed from pre-and post-extraction DHEA 13 spikes at 100 ng/mL to be 95%. In urine, hydrolysis with PaS demonstrated a more than 200-fold increase in DHEA when compared to control experiments not containing PaS (Supporting Information, supplementary figure 9). Selectivity was achieved for DHEA in urine with no matrix interferences observed for any of the 3 MRM transitions monitored. Compared with HpS and acid hydrolysis methods, [33] PaS afforded 25% and 150% increased yields of DHEA in urine respectively. Matrix background observed from all three hydrolysis types was compared using peak areas normalised to DHEA that showed PaS to be equivalent to HpS. These were not as clean as the extract from acid hydrolysis, which was estimated to have one-quarter of the background based on the percentage of total peak areas. However, this result was not surprising, considering the acid hydrolysis procedure included an additional liquid-liquid extraction step.
EAS. The hydrolysis efficiency of PaS for EAS was estimated at 42 ± 3% (n = 3) from buffer spikes at 100 ng mL -1 (EA equiv.). Method recovery without urine matrix was estimated at 92%. Poor selectivity for EA in urine was observed with the 434>169 and 434>239 transitions exhibiting co-eluting matrix interferences that allowed only partial resolution of the EA peak. Additional sample purification was attempted with C18
(Waters, Milford, MA, USA) solid phase extraction of urine samples prior to hydrolysis, but no improvement was found. The 434>239 transition was therefore used to monitor the efficacy of PaS. Hydrolysis with PaS increased EA from undetectable levels to a signal intensity of 2  10 4 in urine (Supporting Information, supplementary figure 10). Analysis of urinary EA was superior using PaS when compared to HpS, with the latter suffering from reduced sensitivity and selectivity. In comparison to the acid hydrolysis, [33] the PaS extract provided similar signal intensity, though the matrix background determined from normalised peak areas was approximately half.
Chemoenzymatic synthesis of 5-androstane-3,17-diol 17-glucuronide (ADG) 1
The commercially available sulfatase preparations are all reported to contain -glucuronidase activity. In To demonstrate this capacity for selective hydrolysis, a short chemoenzymatic synthesis of ADG 1 from EAS 3 was conducted (Scheme 2). Sodium borohydride-mediated reduction of EAS afforded 5-androstane-3,17-diol 3-sulfate (ADS) triethylammonium salt 2. This was then subjected to glucuronylation of the 17-hydroxy group employing a synthetically-derived 1--glucuronyl fluoride 5 donor in conjunction with the glucuronylsynthase catalyst derived from E. coli -glucuronidase. On a small scale, hydrolysis of the mixture containing ADSG 4 (~20 M) with PaS was monitored by LC-MS which showed the consumption of both ADS 2 and ADSG 4 and the accumulation of ADG 1 (Figure 1 ). Under the ESI conditions of this LC-MS analysis the saturated 5-androstane-3,17-diol (AD) liberated from ADS 2 was not observed. In contrast to the selective PaS hydrolysis, the use of HpS resulted in hydrolysis of both sulfate and glucuronide conjugates such that no ADG 1 was produced (data not shown). After demonstrating that the final step in Scheme 2 was possible with the purified PaS, the reaction was scaled up to ~1 mM ADSG 4 (Scheme 2). This produced a mixture of hydrolysis products with ADG 1 remaining as the sole conjugated steroid, which could be readily purified by SPE using an Oasis WAX mixed mode polymeric/weak anion exchange cartridge. [32] The data acquired for this compound was consistent with the proposed structure.
[30]
Discussion
The objective of this research was to discover a sulfatase enzyme capable of the mild and selective hydrolysis of steroid sulfates for analytical applications. In this study, four of the five enzymes tested displayed some steroid sulfatase activity ( Table 1 ). The commercially available crude enzyme preparation
HpS showed the greatest substrate range, with detectable hydrolysis of seven of the nine steroid sulfates investigated. The heterologously expressed and purified PaS also showed broad scope with reasonable activity for six of the nine steroid sulfates. The remaining commercially-derived sulfatase preparations HrS, PvS and KpS showed reduced substrate scope and lower activity against this range of steroid sulfates. Both
PaS and HpS showed useful activity as steroid sulfatases, but none of the five sulfatases tested here provided comprehensive sulfatase activity against the nine steroid substrates tested. Although not investigated as part of this work, we anticipate that PaS will prove useful in the hydrolysis of sulfate metabolites, particularly aryl sulfates, of non-steroidal performance-enhancing drugs, including andarine, [16] and mesocarb.
[17] [18] Previous research by Cawley et al. on mollusc-derived sulfatase preparations uncovered marked preferences for certain steroid sulfates substitution patterns and configurations. [35] This work highlighted that HpS had a particularly broad substrate range when compared to other mollusc sulfatases such as PvS.
The work also highlighted the dependence of HpS activity on the configuration of 3-hydroxyandrostan-17-ones: relatively high activity for DHEAS (3,5-ene), EAS (3,5), and ECS (3,5); intermediate activity for
3-hydroxy-5-androstan-17-one 3-sulfate (3,5); and no activity for AS (3,5). Our measurements of
HpS activity correlate well with this activity profile and include additional data for several steroid 17-sulfates: TS, BS, and NS (17) are hydrolysed whereas ETS (17) is not. Taken together, these results reveal significant differences in enzyme-substrate interactions and kinetic competence for the sulfatases studied.
The bacterial sulfatase PaS appears to be slightly more constrained than the mollusc-derived HpS enzyme preparation given that it cannot hydrolyse ECS. However, in contrast to the recombinantly expressed PaS, it is not certain how many sulfatase isoforms are present in crude HpS preparation or how many contribute to the apparent steroid sulfatase activity. An attempt to isolate the genes responsible for HpS sulfatase activity indicated that at least three sulfatases are present, but only one was cloned as full-length complementary DNA. Attempted expression of this gene in either E. coli or Saccharomyces cerevisiae failed to afford functional enzyme, [36] which serves to highlight the limits of our understanding of these molluscderived sulfatases.
There are subtle differences in activity and substrate range for PaS and HpS (Table 1) . Greater activity per gram of protein is observed for PaS relative to HpS for TS and the 19-nor steroid, NS at 100 M substrate concentration. As noted above, HpS has activity for ECS, whereas PaS does not. The detailed kinetic analysis (Table 2) shows that PaS has lower K M for most substrates, though there was no significant difference for TS. Given that sports drug testing analysis or medical research typically involves low concentrations of steroid compounds (pM-M), a lower K M would be advantageous.
For both enzymes, the substrate range from PNPS to TS show a difference in V max of five orders of magnitude ( Table 2 ). The aryl sulfate esters can be hydrolysed more readily due to the conjugation afforded by the aromatic ring that provides increased stability for the leaving group. [37] [38] The uncatalysed hydrolysis of the S-O bond in near-neutral water for PNPS has been determined as 1.9  10 -10 s -1
, and estimated by extrapolation for the n-pentyl sulfate as 3  10 -26 s -1
. [37] Therefore, even though the maximum rates of hydrolysis for the secondary alkyl sulfate TS is about four to five orders of magnitude slower than the aryl sulfates PNPS and ES, the rate enhancement afforded by HpS or PaS for TS may be significantly greater (~10 11 -fold). It is worth noting that with reasonable catalytic rates for hydrolysis of an extremely stable S-O bond in alkyl sulfates, some alkyl sulfatases provide the greatest rate enhancements of the known enzymes. [37] Differences in maximum velocity were also observed with PaS displaying 25-fold greater V max for PNPS than
HpS. This reflects the enzyme purity, molecular weight and turnover (k cat ) for the pH and temperature used in the assays. It is likely that much of this difference arises due to the lower purity of HpS which is a crude enzyme preparation. In contrast, PaS is purified by affinity chromatography and given the effective posttranslational modification of the active site cysteine to formyl glycine observed on expression in E. coli, [39] the k cat for PaS with PNPS measured in this work would be 26 s -1 at pH 8.8 and 37 °C. This is similar to previously determined k cat of 14 s -1 for PNPS at pH 8 and 25 °C [40] and suggests that the PaS preparation is of high purity with the majority of PaS molecules correctly modified with a formyl glycine residue.
In a urine matrix PaS demonstrated a superior ability to liberate DHEA and EA from their respective sulfate conjugates when compared to HpS, although analysis of the latter substrate was complicated by selectivity issues arising from the urine matrix. Of particular importance, the yield of DHEA following hydrolysis with PaS was 25% greater than that observed for HpS and 150% greater than acid hydrolysis. In terms of the potential for translation to routine sports drug testing analysis, direct hydrolysis of steroid sulfates using
PaS in urine appears satisfactory, without the need for prior extraction.
The PaS enzyme was selected as a candidate steroid sulfatase in part because whole cell cultures of P.
aeruginosa derived from human faecal samples were reported to hydrolyse the sulfate ester of lithocholic acid sulfate. [41] As an enteric microbe, this bacterium may rely on sulfatase activity in order to scavenge sulfate from bile acid salts. [28] Thus it was our hope that this putative sulfatase activity would be extended to other steroid sulfates. Ironically, PaS did not hydrolyse lithocholic acid sulfate in our hands (results not shown) and this failure is consistent with the inability to hydrolyse ECS that also contains the 3,5-configuration of the A-ring. It is possible that the activity observed for P. aeruginosa culture is due to one of the other reported sulfatases: AtsK or SdsA1 that are proposed to employ distinct C-O bond cleavage pathways.
[42] [43] The selective hydrolysis of sulfate conjugates in the presence of glucuronides presents a significant challenge to existing methods. Commercial sulfatase enzyme preparations such as HpS contain glucuronidase activity. [3] Chemical methods of hydrolysis such as strong acid [33] generally show poor discrimination for the hydrolysis of these phase II conjugates. In contrast the selective cleavage of glucuronides can be readily achieved through the agency of E. coli -glucuronidase. The development of PaS as a purified enzyme allowed for the selective hydrolysis of steroid sulfate esters in the presence of glucuronide conjugates. This was exemplified by the short chemoenzymatic synthesis of ADG 1 (Scheme 2)
involving the selective PaS-mediated hydrolysis of a sulfate ester protecting group in the presence of a steroid glucuronide. Thus PaS provides for the targeted investigations of sulfate esters in complex metabolite mixtures that contain glucuronide conjugates.
Conclusions
Forty-five years ago, Cawley et al. [35] highlighted the need to develop a general sulfatase preparation for clinical analysis of steroid sulfates; a need that has remained essentially unmet to this day. [3] Although sulfate ester hydrolysis can be achieved by a range of methods, [3] and the requirement for sulfate hydrolysis has been circumvented to some extent by the direct detection of steroid sulfates using LC-MS-MS methods, mild and selective steroid sulfatase activity would be beneficial for a range of applications including routine screening, confirmatory analysis, GC-IRMS and research.
The recombinantly expressed and purified PaS offers several advantages over HpS and other molluscderived sulfatase preparations in that it has relatively high activity for 3-keto, 17 steroid sulfates and is easily purified. The latter trait allows application in selective sulfate ester hydrolysis, exploited in this work for the synthesis of ADG 1. The PaS enzyme does not meet the requirements of a general steroid sulfatase as it hydrolysed only six of the nine steroid sulfates investigated: no detectable activity was observed for the α-configured sulfates ECS, AS and ETS. Even considering this limitation, access to steroid sulfatase activity without additional enzyme activities is likely to prove beneficial for range of analytical applications.
Further, PaS is amenable to improvement because its amino acid sequence and crystal structure are known and, in contrast to the mollusc-derived counterparts such as HpS, it can be easily expressed in the laboratory. Further engineering will be directed to increasing the substrate scope and improving the catalytic efficiency of the PaS enzyme.
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